NCT03690180 is a clinical trial of serum magnesium in Diabetic Nephropathies, sponsored by Fayoum University.

Who is sponsoring NCT03690180?

NCT03690180 is sponsored by Fayoum University.

What drugs are being tested in NCT03690180?

Interventions in NCT03690180: serum magnesium.

What condition does NCT03690180 study?

NCT03690180 studies Diabetic Nephropathies.

Is NCT03690180 still recruiting?

NCT03690180 is currently completed. Last updated 10 September 2019.

Last reviewed 2019-09-10 · How we verify

NCT03690180

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hypomagnesemia and Diabetic Nephropathy

Completed Last updated 10 September 2019

What this trial tests

trial testing serum magnesium in Diabetic Nephropathies in 100 participants. Completed in 28 February 2018.

Timeline

1 January 2018

Primary endpoint
30 January 2018

28 February 2018

Quick facts

Lead sponsor	Fayoum University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 January 2018
Primary completion	30 January 2018
Estimated completion	28 February 2018
Sites	1 location across Egypt

Drugs / interventions tested

serum magnesium

Conditions studied

Diabetic Nephropathies — all drugs for Diabetic Nephropathies →

Sponsor

Fayoum University

Who can join

20 and older, any sex, with Diabetic Nephropathies. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To find if there is a corrolatation between Microalbuminurea and diabetic retinopathy, in daibetic patients

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Diabetic Nephropathies

Currently open trials in the same condition.

NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting
NCT07187713 — ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases · Phase 4 · recruiting
NCT06778018 — Nutritional Outcomes of Lotus Seed (Nelumbo Nucifera) on Diabetic Sensorimotor Polyneuropathy · NA · recruiting
NCT06441591 — Clinical Outcome of Vinpocetine in Diabetic Nephropathy · Phase 2, PHASE3 · recruiting
NCT06431477 — Efficacy and Safety of Telmisartan Compared With Losartan · Phase 4 · recruiting

Other Fayoum University trials

Trials by the same sponsor.

NCT07536620 — Metformin and Alveolar Cleft · Phase 2 · not yet recruiting
NCT07444970 — Comparative Evaluation of Xenograft Alone and Sticky Bone in Sinus Lift With Concurrent Implant Placement · NA · not yet recruiting
NCT07394179 — Transforming Channel Osteotomy Into Tunnel Osteotomy in Zygomatic Implant Preparation · NA · not yet recruiting
NCT07277348 — Analysis of The Outcomes of Therapeutic Photorefractive Keratectomy Combined With Prophylactic Accelerated Cross-Linking · NA · not yet recruiting
NCT07330726 — Lidocaine Patch and Lower Third Molar · Phase 3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03690180 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fayoum University
Last refreshed: 10 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03690180.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing